Advertisement

Image-Guided Radiotherapy in Lung Cancer

  • Percy Lee
  • Patrick Kupelian
Chapter
Part of the Medical Radiology book series (MEDRAD)

Abstract

Technological advances in image guidance have led to improvements in outcome for lung cancer patients treated with radiation therapy. In particular advancements in 2-Dimensional to now 3 and 4-Dimensional treatment planning as well as the use of functional imaging such as FDG-PET/CT have allowed for more accurate targeting of radiation therapy to areas of disease while limiting collateral damage to surrounding normal tissue. Patient specific margins are now applied to individual patients and are substantially less than what has been used in the previous era. This has allowed for radiation dose-escalation to the tumor while maximally sparing the surrounding organs at risk and has translated into improved tumor control and decrease in toxicities clinically. In-treatment room stereoscopic X-ray imaging with or without implanted fiducial markers as well as volumetric kilovoltage or megavoltage cone-beam CT have allowed clinician to reliably deliver the planned treatment daily to the intended target despite the smaller margins of error. Image-guidance is an important evolving component of radiation therapy for lung cancer and is an area of intense research interest.

Keywords

Stereotactic Body Radiation Therapy Gross Tumor Volume Fiducial Marker Volumetric Imaging Electronic Portal Imaging Device 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Bradley J, Thorstad WL, Mutic S et al (2004) Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59:78–86PubMedCrossRefGoogle Scholar
  2. De Neve W, Van den Heuvel F, De Beukeleer M et al (1992) Routine clinical on-line portal imaging followed by immediate field adjustment using a tele-controlled patient couch. Radiother Oncol 24:45–54PubMedCrossRefGoogle Scholar
  3. Korreman S, Mostafavi H, Le QT et al (2006) Comparison of respiratory surrogates for gated lung radiotherapy without internal fiducials. Acta Oncol 45:935–942PubMedCrossRefGoogle Scholar
  4. Kothary N, Heit JJ, Louie JD et al (2009) Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J Vasc Interv Radiol 20:235–239PubMedCrossRefGoogle Scholar
  5. Kupelian PA, Forbes A, Willoughby TR et al (2007) Implantation and stability of metallic fiducials within pulmonary lesions. Int J Radiat Oncol Biol Phys 69:777–785PubMedCrossRefGoogle Scholar
  6. Liu HH, Balter P, Tutt T et al (2007) Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 68:531–540PubMedCrossRefGoogle Scholar
  7. Mac Manus MP, Hicks RJ (2007) Impact of PET on radiation therapy planning in lung cancer. Radiol Clin North Am 45:627–638PubMedCrossRefGoogle Scholar
  8. Michalski D, Sontag M, Li F et al (2008) Four-dimensional computed tomography-based interfractional reproducibility study of lung tumor intrafractional motion. Int J Radiat Oncol Biol Phys 71:714–724PubMedCrossRefGoogle Scholar
  9. Nehmeh SA, Erdi YE, Pan T et al (2004a) Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 31:3179–3186Google Scholar
  10. Nehmeh SA, Erdi YE, Pan T et al (2004) Quantitation of respiratory motion during 4D-PET/CT acquisition. Med Phys 31:1333–1338Google Scholar
  11. Onishi H, Araki T, Shirato H et al (2004) Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101:1623–1631PubMedCrossRefGoogle Scholar
  12. Perez CA, Bauer M, Edelstein S et al (1986) Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys 12:539–547PubMedCrossRefGoogle Scholar
  13. Prenzel KL, Monig SP, Sinning JM et al (2003) Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 123:463–467PubMedCrossRefGoogle Scholar
  14. Richter A, Wilbert J, Baier K et al (2010) Feasibility study for markerless tracking of lung tumors in stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 78:618–627PubMedCrossRefGoogle Scholar
  15. Seppenwoolde Y, Shirato H, Kitamura K et al (2002) Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys 53:822–834PubMedCrossRefGoogle Scholar
  16. Shimizu S, Shirato H, Kagei K et al (2000) Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. Int J Radiat Oncol Biol Phys 46:1127–1133PubMedCrossRefGoogle Scholar
  17. Shirato H, Shimizu S, Kunieda T et al (2000) Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys 48:1187–1195PubMedCrossRefGoogle Scholar
  18. Timmerman R, Paulus R, Galvin J et al (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303:1070–1076PubMedCrossRefGoogle Scholar
  19. Wu J, Lei P, Shekhar R et al (2009) Do tumors in the lung deform during normal respiration? An image registration investigation. Int J Radiat Oncol Biol Phys 75:268–275PubMedCrossRefGoogle Scholar
  20. Xia T, Li H, Sun Q et al (2006) Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66:117–125PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg  2011

Authors and Affiliations

  1. 1.Department of Radiation OncologyUniversity of California at Los AngelesLos AngelesUSA

Personalised recommendations